Schaffhausen, Switzerland - December 18, 2015, Schaffhausen, Switzerland - TE Connectivity Ltd. has nominated Terrence Curtin, John Davidson and Mark Trudeau to stand for election to the board of directors, scheduled for March 2, 2016.
Article continues below
Mr. Curtin was appointed President of TE Connectivity (TE) in March 2015 as part of the Board of Director's succession planning.
In this role as President, Mr. Curtin has responsibility for all of the company's Connectivity and Sensor businesses and Mergers & Acquisitions activities.
Prior to his current role, Mr. Curtin served as President, Industrial Solutions segment which includes TE's Aerospace, Defense, Oil and Gas business; Energy business; and Industrial and Medical businesses.
Prior to that he served as Executive Vice President and Chief Financial Officer of TE. Mr. Curtin is also a Certified Public Accountant.
Mr. Curtin has a Bachelor's of Science degree in Accounting from Albright College, Pennsylvania, U.S., and is a member of its Board of Trustees.
Mr. Davidson is a Certified Public Accountant, with more than 30 years of leadership experience across multiple industries. Mr. Davidson held a variety of leadership roles at Tyco International Ltd. and Dell Inc. and financial leadership roles at Eastman Kodak Company.
He is a member of the Board of Trustees of the Financial Accounting Foundation which oversees financial accounting and reporting standards setting processes for the United States. He also serves on the Board of Governors of the Financial Industry Regulatory Authority (FINRA).
Mr. Davidson holds a Bachelor's of Science degree in Accounting from St. John Fisher College and a MBA in Finance from the University of Rochester.
He is a director of DaVita HealthCare Partners Inc., Legg Mason, Inc. and Pentair plc.
Mr. Trudeau is the President, Chief Executive Officer and director of Mallinckrodt plc, a global specialty biopharmaceutical and imaging business that develops, manufactures, markets and distributes specialty pharmaceutical products and imaging agents.
Mr. Trudeau held executive leadership positions at Covidien plc, Bayer HealthCare Pharmaceuticals LLC USA, Bayer HealthCare Pharmaceuticals, Bristol-Myers Squibb and Abbott Laboratories.
Mr. Trudeau brings experience as a public company executive officer and director, along with a record of executive leadership and global business expertise in many areas including strategy, operations and management. ■